Pixie Dust Technologies, which promotes university-derived technologies from Japan, has received $34.7m in a round that included KDDI, Kansai Electric Power, NEC, Toppan, Dai-ichi Life and Dentsu.
The intermediary close of PSL's deep tech-oriented fund comes after additional contributions from the EIF, Bpifrance and Vilmorin & Cie.
Cambridge Innovation Capital has celebrated an exit as Bicycle Therapeutics successfully lists in the US.
University of Calgary-born Parvus Therapeutics has inked an $800m deal with Genentech to develop and commercialise treatments for autoimmune diseases.
After a year of countless exits in the ecosystem, many among the most significant yet – so much so that five nominees were not enough to recognise them all – the Award for Exit of the Year was one of the most difficult to determine.
With the growing focus on food sustainability, University of California (UC) Santa Barbara-founded food preservative developer Apeel Science is a particularly apt selection for the Technology of the Year award.
Winner of the CVC Spinout Investment of the Year: Ribon Therapeutics - Novartis Venture Fund, Johnson & Johnson Innovation–JJDC, Takeda Ventures, Celgene
Greg Milani, a senior managing director at Stanford’s endowment, is reportedly leaving his position later this year with the university locked in a potentially damaging lawsuit with MedWhat.